The Claim
Deiodinase activity, as measured by SPINA-GD, is significantly lower in patients with exogenous thyrotoxicosis due to levothyroxine therapy than in patients with endogenous hyperthyroidism caused by Graves' disease or toxic adenoma, indicating reduced peripheral conversion of thyroxine (T4) to triiodothyronine (T3) in the absence of thyroid gland stimulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People taking synthetic thyroid hormone (levothyroxine) for thyroid conditions show lower levels of a specific enzyme activity that converts T4 to T3 in the body, compared to people whose thyroid glands overproduce hormones due to Graves' disease or a toxic nodule.
See the scientific wording
Deiodinase activity, measured as SPINA-GD, is significantly lower in patients with exogenous thyrotoxicosis due to levothyroxine therapy compared to those with endogenous hyperthyroidism from Graves' disease or toxic adenoma, reflecting impaired peripheral conversion of T4 to T3 in the absence of thyroid gland stimulation.
What the research says
1 studyWhen people take too much thyroid hormone medicine, their body slows down its own process of converting that medicine into its active form, unlike in natural overactive thyroid disease where this conversion stays normal. This study shows that the body’s conversion system is less active when the thyroid isn’t working at all.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.